West Virginia University Logo

November 26, 2012

SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv

Return to Listserv Archive Home

November 26, 2012 (PDF version)
 
Prescription Drug Abuse Webinar, Tomorrow, Tuesday, Nov. 27, 1:30 p.m. EST
 
Colleagues: 
 
SAMHSA's Preventing Prescription Abuse in the Workplace (PAW) project is excited to announce its first Webinar--tomorrow, Tuesday, Nov. 27, 2012, from 1:30 to 3:00 p.m. EST--on Prescription Drug Abuse Prevention.
 
The Webinar will be led by RTI International senior researcher Scott Novak.
 
A preeminent national expert in prescription drug abuse, Dr. Novak has led several National Institutes of Health-funded grants on the causes and consequences of prescription drug abuse. He has served as a national advisory board member to the U.S. Food and Drug Administration on issues related to abuse liability of prescription pain relievers and ADHD stimulant medications.
  
This first Webinar will provide an overview of the history of the prescription drug abuse epidemic. Dr. Novak will discuss the social groups most affected by prescription drug abuse and provide a "gentle" introduction to the psychopharmacology of prescription medications, such as
 

  • What is the difference between hydrocodone and oxycodone?
  • What does "extended release" mean?
  • How are Vicodin and Oxycontin different?

 
In addition to shedding light on this important issue, the Webinar will provide attendees with an opportunity to share their own ideas about designing effective prevention programming, including
 

  • How to create attractive prevention messages
  • Which groups to target
  • How to select venues to maximize participation

  
Webinar Details
 
Date: Tuesday, November 27, 2012
 
Time: 1:30 p.m. EST
 
Duration: 90 minutes
 
For participants to access the Internet portion, type URL https://www.mymeetings.com/nc/join/
 
1. Type conference number PW7865109
 
2. Type audience passcode Prescription
 
3. Enter the required fields.
 
4. Indicate that you have read the Privacy Policy.
 
5. Click on Proceed
 
For participants to access to the audio portion: Dial the toll-free number 888.566.1821
 
Audio Participant Passcode: Prescription
 
Participants should access the Internet portion 30 minutes before its scheduled start to ensure you can log on. We will be using Microsoft Live Meeting software. It should load onto your computer once you click on the link. However, if you have problems or should you need assistance, please contact the Product Help Desk at 800.857.8777, option 3.
 
We hope you will be able to join us on Tuesday, Nov. 27, 2012, from 1:30 to 3:00 p.m. Eastern Time.
 
The PAW project is planning a second prescription drug abuse Webinar in early 2013 that will cover model prescription drug prevention programs.
 
Please e-mail Rekaya Gibson at rgibson@pire.org with questions or comments about the SAMHSA Prescription Drug Abuse Listserv.  
 
 
About PAW and the Listserv
The PAW TA Center addresses prescription drug abuse--a growing public health problem with increasing burdens on workers, workplaces, and our economy. Prescription drug abuse affects workplace productivity and increases employee absenteeism, employee presenteeism, and workers' compensation claims. On a wider scale, overdose deaths linked to prescription opioids tripled from 1999 to 2006, and prescription drug abuse killed more Americans in 2009 than died that year in auto crashes.
 
Send your request for PAW technical assistance to PAW-TA@pire.org or contact Rekaya Gibson at 504.261.8107 or Deborah Galvin at 240.276.2721. Requests are subject to SAMHSA approval. You will be notified of the status of your request.
 
We aim to conduct systematic and inclusive searches of professional journals, leading newspapers and magazines, and federal websites, as well as contributions from listserv subscribers (please e-mail suggestions to rgibson@pire.org). We will send links to articles along with brief descriptions of those articles. As we develop the listserv, however, we hope to add commentary and invite feedback from subscribers. Our goal is to expand the listserv to become a widely used and recognized source of the most current and authoritative information on prescription drug abuse--especially in workplaces.

Return to Listserv Archive Home